# First Interstate Bancsystem Inc: financial statements, quarterly

FIBK · Nasdaq · CIK 860413 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fibk.md) · [Financials](/companies/fibk/financials.md) · [Filings](/companies/fibk/filings.md) · [Insiders](/companies/fibk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fibk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [109](/filings/0000860413-24-000130.md) | [117 d](/filings/0000860413-24-000016.md) | [125](/filings/0000860413-24-000066.md) | [122](/filings/0000860413-24-000118.md) | [123](/filings/0000860413-24-000130.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [22.0](/filings/0000860413-24-000130.md) | [19.4 d](/filings/0000860413-26-000011.md) | [18.3](/filings/0000860413-25-000060.md) | [18.4](/filings/0000860413-25-000117.md) | [17.2](/filings/0000860413-25-000165.md) | [14.6 d](/filings/0000860413-26-000011.md) | [16.2](/filings/0000860413-26-000038.md) | [21.8](/filings/0000860413-26-000084.md) | [21.2](/filings/0000860413-25-000165.md) | [30.4 d](/filings/0000860413-26-000011.md) | [17.3](/filings/0000860413-26-000038.md) | [24.3](/filings/0000860413-26-000084.md) |
| Net income | $m | [72.7](/filings/0000860413-24-000130.md) | [61.5 d](/filings/0000860413-26-000011.md) | [58.4](/filings/0000860413-25-000060.md) | [60.0](/filings/0000860413-25-000117.md) | [55.5](/filings/0000860413-25-000165.md) | [52.1 d](/filings/0000860413-26-000011.md) | [50.2](/filings/0000860413-26-000038.md) | [71.7](/filings/0000860413-26-000084.md) | [71.4](/filings/0000860413-25-000165.md) | [109 d](/filings/0000860413-26-000011.md) | [60.2](/filings/0000860413-26-000038.md) | [83.9](/filings/0000860413-26-000084.md) |
| Diluted EPS | $ per share | [0.70](/filings/0000860413-24-000130.md) | not reported | [0.57](/filings/0000860413-25-000060.md) | [0.58](/filings/0000860413-25-000117.md) | [0.54](/filings/0000860413-25-000165.md) | not reported | [0.49](/filings/0000860413-26-000038.md) | [0.69](/filings/0000860413-26-000084.md) | [0.69](/filings/0000860413-25-000165.md) | not reported | [0.61](/filings/0000860413-26-000038.md) | [0.87](/filings/0000860413-26-000084.md) |
| Basic EPS | $ per share | [0.70](/filings/0000860413-24-000130.md) | not reported | [0.57](/filings/0000860413-25-000060.md) | [0.58](/filings/0000860413-25-000117.md) | [0.54](/filings/0000860413-25-000165.md) | not reported | [0.49](/filings/0000860413-26-000038.md) | [0.69](/filings/0000860413-26-000084.md) | [0.69](/filings/0000860413-25-000165.md) | not reported | [0.61](/filings/0000860413-26-000038.md) | [0.87](/filings/0000860413-26-000084.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [30.5](/filings/0000860413-23-000186.md) | [30.7](/filings/0000860413-25-000022.md) | [30.1](/filings/0000860413-24-000066.md) | [30.3](/filings/0000860413-24-000118.md) | [29.6](/filings/0000860413-24-000130.md) | [29.1](/filings/0000860413-26-000011.md) | [28.3](/filings/0000860413-25-000060.md) | [27.6](/filings/0000860413-25-000117.md) | [27.3](/filings/0000860413-25-000165.md) | [26.6](/filings/0000860413-26-000084.md) | [26.4](/filings/0000860413-26-000038.md) | [25.9](/filings/0000860413-26-000084.md) |
| Total liabilities | $bn | [27.5](/filings/0000860413-23-000186.md) | [27.4](/filings/0000860413-25-000022.md) | [26.9](/filings/0000860413-24-000066.md) | [27.1](/filings/0000860413-24-000118.md) | [26.2](/filings/0000860413-24-000130.md) | [25.8](/filings/0000860413-26-000011.md) | [24.9](/filings/0000860413-25-000060.md) | [24.1](/filings/0000860413-25-000117.md) | [23.9](/filings/0000860413-25-000165.md) | [23.2](/filings/0000860413-26-000084.md) | [23.1](/filings/0000860413-26-000038.md) | [22.6](/filings/0000860413-26-000084.md) |
| Long-term debt | $bn | not reported | [0.1](/filings/0000860413-24-000016.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.1](/filings/0000860413-24-000130.md) | [3.2](/filings/0000860413-26-000011.md) | [3.2](/filings/0000860413-25-000117.md) | [3.2](/filings/0000860413-25-000165.md) | [3.4](/filings/0000860413-25-000165.md) | [3.3](/filings/0000860413-26-000084.md) | [3.4](/filings/0000860413-26-000084.md) | [3.4](/filings/0000860413-26-000084.md) | [3.4](/filings/0000860413-25-000165.md) | [3.4](/filings/0000860413-26-000084.md) | [3.4](/filings/0000860413-26-000084.md) | [3.3](/filings/0000860413-26-000084.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [129 d](/filings/0000860413-24-000130.md) | [69.3 d](/filings/0000860413-26-000011.md) | [87.6](/filings/0000860413-25-000060.md) | [82.3 d](/filings/0000860413-25-000117.md) | [89.9 d](/filings/0000860413-25-000165.md) | [95.2 d](/filings/0000860413-26-000011.md) | [78.5](/filings/0000860413-26-000038.md) | [68.1 d](/filings/0000860413-26-000084.md) | [91.7 d](/filings/0000860413-25-000165.md) | [67.3 d](/filings/0000860413-26-000011.md) | [55.0](/filings/0000860413-26-000038.md) | [57.9 d](/filings/0000860413-26-000084.md) |
| Dividends paid | $m | [49.2 d](/filings/0000860413-24-000130.md) | [48.7 d](/filings/0000860413-26-000011.md) | [48.8](/filings/0000860413-25-000060.md) | [49.0 d](/filings/0000860413-25-000117.md) | [49.1 d](/filings/0000860413-25-000165.md) | [49.0 d](/filings/0000860413-26-000011.md) | [48.0](/filings/0000860413-26-000038.md) | [49.1 d](/filings/0000860413-26-000084.md) | [49.1 d](/filings/0000860413-25-000165.md) | [48.1 d](/filings/0000860413-26-000011.md) | [45.7](/filings/0000860413-26-000038.md) | [46.0 d](/filings/0000860413-26-000084.md) |
| Share repurchases | $m | [0.0 d](/filings/0000860413-24-000130.md) | [32.2 d](/filings/0000860413-26-000011.md) | [1.1](/filings/0000860413-25-000060.md) | [0.0 d](/filings/0000860413-25-000117.md) | [0.1 d](/filings/0000860413-25-000165.md) | [0.0 d](/filings/0000860413-26-000011.md) | [3.2](/filings/0000860413-26-000038.md) | [0.0 d](/filings/0000860413-26-000084.md) | [27.5 d](/filings/0000860413-25-000165.md) | [91.2 d](/filings/0000860413-26-000011.md) | [87.7](/filings/0000860413-26-000038.md) | [69.5 d](/filings/0000860413-26-000084.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [107](/filings/0000860413-23-000186.md) | [104](/filings/0000860413-24-000066.md) | [104](/filings/0000860413-24-000118.md) | [104](/filings/0000860413-24-000130.md) | [103](/filings/0000860413-25-000060.md) | [103](/filings/0000860413-25-000117.md) | [103](/filings/0000860413-25-000165.md) | [103](/filings/0000860413-26-000038.md) | [103](/filings/0000860413-26-000084.md) | [103](/filings/0000860413-25-000165.md) | [99.2](/filings/0000860413-26-000038.md) | [96.8](/filings/0000860413-26-000084.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 95,304,607 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0000860413-26-000084.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.